Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016	Mar '15 Mar 31, 2015	Mar '14 Mar 31, 2014	Mar '13 Mar 31, 2013
Japan Revenue	105.51B	110.11B	117.30B
Japan Revenue Growth	-4.18%	-6.13%	-4.26%
North America Revenue	394.46B	413.81B	351.25B
North America Revenue Growth	-4.68%	17.81%	9.03%
Europe Revenue	268.41B	254.62B	236.77B
Europe Revenue Growth	5.42%	7.54%	6.57%
China Revenue	87.17B	95.72B	106.34B
China Revenue Growth	-8.94%	-9.98%	-9.19%
Asia and Oceania Revenue (Post-FY2019 Reporting)	98.10B	93.69B	87.99B
Asia and Oceania Revenue (Post-FY2019 Reporting) Growth	4.71%	6.48%	13.08%
Asia and Oceania Revenue (Pre-FY2020 Reporting)	185.27B	189.41B	194.32B
Asia and Oceania Revenue (Pre-FY2020 Reporting) Growth	-2.19%	-2.53%	-0.30%
Other Countries Revenue	33.52B	28.84B	26.11B
Other Countries Revenue Growth	16.22%	10.46%	29.42%

Revenue Breakdown

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016	Mar '15 Mar 31, 2015	Mar '14 Mar 31, 2014	Mar '13 Mar 31, 2013
Endoscopic Solutions Division Revenue	636.14B	586.62B
Endoscopic Solutions Division Revenue Growth	8.44%	6.30%
Therapeutic Solutions Division Revenue	360.66B	337.33B
Therapeutic Solutions Division Revenue Growth	6.92%	6.01%
Total Medical Solutions Division Revenue	996.80B	923.95B
Total Medical Solutions Division Revenue Growth	7.89%	6.20%
Other Division Revenue (Post-FY2024 Reporting)	530.00M	1.80B
Other Division Revenue (Post-FY2024 Reporting) Growth	-70.62%	-

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016	Mar '15 Mar 31, 2015	Mar '14 Mar 31, 2014	Mar '13 Mar 31, 2013
Gastrointestinal Solutions Division Revenue	667.84B	674.04B	-
Gastrointestinal Solutions Division Revenue Growth	-0.92%	-	-
Surgical & Interventional Solutions Division Revenue	319.33B	322.76B	-
Surgical & Interventional Solutions Division Revenue Growth	-1.06%	-	-

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016	Mar '15 Mar 31, 2015	Mar '14 Mar 31, 2014	Mar '13 Mar 31, 2013
Endoscopic Solutions Division Operating Profit	141.40B	104.68B
Endoscopic Solutions Division Operating Profit Growth	35.07%	-31.48%
Therapeutic Solutions Division Operating Profit	61.45B	-8.47B
Total Medical Solutions Division Operating Profit	202.85B	96.22B
Total Medical Solutions Division Operating Profit Growth	110.82%	-55.55%
Other Division Operating Profit (Post-FY2024 Reporting)	-473.00M	-287.00M
Eliminations from Division Operating Profit	-39.92B	-44.54B

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016	Mar '15 Mar 31, 2015	Mar '14 Mar 31, 2014	Mar '13 Mar 31, 2013
Gastrointestinal Solutions Division Operating Profit	149.90B	171.44B	-
Gastrointestinal Solutions Division Operating Profit Growth	-12.57%	-	-
Surgical & Interventional Solutions Division Operating Profit	-2.60B	15.27B	-

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016	Mar '15 Mar 31, 2015	Mar '14 Mar 31, 2014	Mar '13 Mar 31, 2013
ESD - GI Endoscopy Revenue Growth Rate After FX Adjustment	3.00%	-3.00%
ESD - Surgical Endoscopy Revenue Growth Rate After FX Adjustment	5.00%	-3.00%
ESD - Medical Service Revenue Growth Rate After FX Adjustment	5.00%	8.00%
Total Endoscopic Solutions Division (ESD) Revenue Growth Rate After FX Adjustment	4.00%	1.00%
TSD - GI EndoTherapy Revenue Growth Rate After FX Adjustment	2.00%	6.00%
TSD - Urology Revenue Growth Rate After FX Adjustment	6.00%	-1.00%
TSD - Respiratory Revenue Growth Rate After FX Adjustment	10.00%	-3.00%
TSD - Other Therapeutic Areas Revenue Growth Rate After FX Adjustment	-7.00%	-5.00%
Total Therapeutic Solutions Division (TSD) Revenue Growth Rate After FX Adjustment	3.00%	-

Updated Dec 31, 2025. Data Source: Fiscal.ai.